190 related articles for article (PubMed ID: 1510002)
1. Pharmacologic treatment of supraventricular tachycardia: the German experience.
Lüderitz B; Manz M
Am J Cardiol; 1992 Aug; 70(5):66A-73A; discussion 73A-74A. PubMed ID: 1510002
[TBL] [Abstract][Full Text] [Related]
2. Supraventricular tachycardia and pre-excitation syndromes: pharmacological therapy.
Manz M; Lüderitz B
Eur Heart J; 1993 Sep; 14 Suppl E():91-8. PubMed ID: 8223763
[TBL] [Abstract][Full Text] [Related]
3. Using the right drug: a treatment algorithm for regular supraventricular tachycardias.
Lévy S; Ricard P
Eur Heart J; 1997 May; 18 Suppl C():C27-32. PubMed ID: 9152672
[TBL] [Abstract][Full Text] [Related]
4. [Drug therapy in supraventricular arrhythmia].
Follath F; Candinas R; Meyer B
Schweiz Rundsch Med Prax; 1992 Apr; 81(18):579-81. PubMed ID: 1594845
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia.
Luedtke SA; Kuhn RJ; McCaffrey FM
Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and Management of Common Types of Supraventricular Tachycardia.
Helton MR
Am Fam Physician; 2015 Nov; 92(9):793-800. PubMed ID: 26554472
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
Honerjäger P; Schmidt G
Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH
Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636
[TBL] [Abstract][Full Text] [Related]
9. [An analysis of clinical characteristics and acute treatment of supraventricular tachycardia in children from a multicenter study].
Li XM; Ge HY; Liu XQ; Shi L; Guo BJ; Li MT; Jiang H; Zhang Y; Liu HJ; Zheng XC; Li AJ; Zhang YY
Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):13-18. PubMed ID: 29342991
[No Abstract] [Full Text] [Related]
10. Supraventricular tachyarrhythmias during the intrauterine, neonatal, and infant period: A 10-year population-based study.
Bjeloševič M; Illíková V; Tomko J; Olejník P; Chalupka M; Hatala R
Pacing Clin Electrophysiol; 2020 Jul; 43(7):680-686. PubMed ID: 32459027
[TBL] [Abstract][Full Text] [Related]
11. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
Price JF; Kertesz NJ; Snyder CS; Friedman RA; Fenrich AL
J Am Coll Cardiol; 2002 Feb; 39(3):517-20. PubMed ID: 11823091
[TBL] [Abstract][Full Text] [Related]
12. Supraventricular tachycardia.
Chauhan VS; Krahn AD; Klein GJ; Skanes AC; Yee R
Med Clin North Am; 2001 Mar; 85(2):193-223, ix. PubMed ID: 11233946
[TBL] [Abstract][Full Text] [Related]
13. [Electrophysiological testing of multiple antiarrhythmic drugs in patients with paroxysmal supraventricular tachycardia after chronic oral administration].
Nishino T
Hokkaido Igaku Zasshi; 1989 Nov; 64(6):738-48. PubMed ID: 2606448
[TBL] [Abstract][Full Text] [Related]
14. Safety of flecainide versus propafenone for the long-term management of symptomatic paroxysmal supraventricular tachyarrhythmias. Report from the Flecainide and Propafenone Italian Study (FAPIS) Group.
Chimienti M; Cullen MT; Casadei G
Eur Heart J; 1995 Dec; 16(12):1943-51. PubMed ID: 8682031
[TBL] [Abstract][Full Text] [Related]
15. The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
Ergül Y; Özyılmaz İ; Saygı M; Tola HT; Akdeniz C; Tuzcu V
Turk Kardiyol Dern Ars; 2015 Oct; 43(7):607-12. PubMed ID: 26536985
[TBL] [Abstract][Full Text] [Related]
16. [Current treatment of supraventricular tachycardia: drug therapy].
Manz M; Lüderitz B
Z Gesamte Inn Med; 1993 Sep; 48(9):430-8. PubMed ID: 8212748
[TBL] [Abstract][Full Text] [Related]
17. [Effectiveness of D,L-sotalol in post-ablative atrial arrhythmias in patients with atrial fibrillation treated with radiofrequency ablation].
Mihálcz A; Földesi C; Kardos A; Ladunga K; Szili-Török T
Orv Hetil; 2009 Sep; 150(36):1694-700. PubMed ID: 19709984
[TBL] [Abstract][Full Text] [Related]
18. Serial electrophysiologic testing of drug therapy in supraventricular tachycardia related to accessory pathways.
Nagi HM; Pinski SL; Mokhtar S; Saad Y; Maloney JD
Cleve Clin J Med; 1990 Oct; 57(7):622-6. PubMed ID: 2225447
[TBL] [Abstract][Full Text] [Related]
19. Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia.
Hamer AW; Strathmore N; Vohra JK; Hunt VD
Pacing Clin Electrophysiol; 1993 Jul; 16(7 Pt 1):1394-400. PubMed ID: 7689205
[TBL] [Abstract][Full Text] [Related]
20. Elimination of Benign Ventricular Premature Beats or Ventricular Tachycardia with Catheter Ablation versus Two Different Optimal Antiarrhythmic Drug Treatment Regimens (Sotalol or Verapamil/Flecainide).
Haanschoten DM; Vernooy K; Beukema RJ; Szili-Torok T; Ter Bekke RMA; Khan M; de Jong JSSG; Otten AM; Adiyaman A; Smit JJJ; Delnoy PPHM; Ramdat Misier AR; Elvan A
Cardiology; 2020; 145(12):795-801. PubMed ID: 32841937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
